Expansion of Bioconjugation Facility
Sector: Manufacturing (Industrial) • Location: St. Louis, Missouri, United States
Source: Contract Pharma
MilliporeSigma is investing $76 million to expand its ADC manufacturing capabilities at its Bioconjugation Center of Excellence in St. Louis, Missouri. This expansion will triple the existing capacity and enhance the company's contract development and manufacturing organization (CDMO) offerings, aiming to support early-stage and commercial bioconjugates more effectively.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | Planned |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | MilliporeSigma is investing $76 million to expand its ADC manufacturing capabilities at its Bioconjugation Center of Excellence in St. Louis, Missouri. This expansion will triple the existing capacity and enhance the company's contract development and manufacturing organization (CDMO) offerings, aiming to support early-stage and commercial bioconjugates more effectively. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |